The science behind one of the most under researched aspects of women’s sexual health – and what the evidence says you can actually do
Why This Conversation Matters
Difficulty reaching orgasm – or finding that orgasms feel less intense, take longer, or occur less frequently than before – is one of the most common sexual complaints among women over 40. Yet it is almost never discussed openly, rarely raised in medical appointments, and frequently mistaken for something psychological, relational, or simply inevitable.
It is none of those things. The female orgasm is a complex physiological and psychological response essential for sexual well-being and overall health. Historically misinterpreted, its significance is now better understood through modern research integrating neurobiological, hormonal, and psychological factors. Changes in orgasmic function with age are real, measurable, and – critically – addressable.
The Anatomy of Orgasm: What Is Actually Happening
The female orgasm involves interplay between anatomical structures such as the clitoris, vagina, and pelvic floor muscles, as well as neural pathways and hormonal interactions. It is not a single event – it is a coordinated cascade involving the autonomic nervous system, the brain’s reward circuits, genital blood flow, and muscular contraction.
The female sexual response cycle is typically divided into interrelated phases: desire, arousal, orgasm, and resolution. However, research by Rosemary Basson and colleagues has highlighted that women’s sexual response often follows a nonlinear pattern in which emotional intimacy, contextual factors, and subjective arousal play central roles. Often, sexual desire may emerge during or after arousal rather than preceding it, challenging the traditional linear models of sexual function.
This nonlinear model is critical to understand at midlife, because it means that waiting to “feel like it” before beginning sexual activity may work against you – arousal can build during, not only before. Context, safety, and emotional connection become increasingly influential triggers as hormonal priming diminishes.
What Changes After 40 – The Three Biological Mechanisms
1. Reduced Genital Sensation
Vibration thresholds increase with advancing age at all genital sites. Multilinear regression analysis indicates that menopause and increasing age negatively affect sensation. In practical terms, this means that the same stimulation that reliably produced orgasm in your 30s may now be insufficient – not because anything is wrong with you, but because the sensory threshold has shifted upward. More direct, sustained, and focused clitoral stimulation is typically needed.
2. Hormonal Changes – Estrogen, Testosterone, and the Orgasm Circuit
Estrogen maintains genital blood flow, vaginal elasticity, clitoral engorgement capacity, and the sensitivity of nerve endings throughout the vulvar tissue. As levels fall, all of these are compromised. A steep decline in arousal, orgasm, dyspareunia, and satisfaction scores was observed in women aged 46–50. Arousal was the most affected domain, followed by satisfaction.
Testosterone plays a parallel role. In women, it directly influences sexual motivation and the neurological reward response to orgasm. Its decline across perimenopause – often preceding estrogen decline – contributes to both reduced desire and diminished orgasmic intensity.
3. Pelvic Floor Changes
Aging has muscular, hormonal, and neurological effects on the pelvic floor. Muscular changes lead to decreased force output and weakness on clinical examination. Hormonal effects exacerbate pelvic tissue changes, most notably in the postmenopausal woman.
The pelvic floor muscles contract rhythmically during orgasm – this is what creates the sensation of release and pulsation. When these muscles are weakened, poorly coordinated, or in chronic tension (a pattern common in women experiencing pain), the quality and intensity of orgasm declines. Perimenopausal women with pelvic floor dysfunction have worse sexual function than women with functional pelvic floor muscles, especially in terms of orgasm, sexual satisfaction, and total Female Sexual Function Index scores.
Female Orgasmic Disorder (FOD): When to Name It
Female orgasmic disorder (FOD) is characterized by persistent difficulty in achieving orgasm and significantly affects emotional and relational well-being. It is classified as primary (lifelong) or secondary (acquired) and is influenced by psychosocial, relational, and medical factors.
Secondary FOD – where orgasms were achievable before but have become difficult or absent – is particularly common in perimenopause and menopause and is directly linked to the biological changes described above. It is a clinical diagnosis that merits treatment, not a personal failing.
The highest prevalence of sexual dysfunction is often observed in perimenopausal women aged 51–59, where contributing factors may include lower educational attainment, relationship stress, and comorbid conditions such as diabetes, hypertension, or chronic vulvar inflammation.
What the Evidence Says Actually Works
Pelvic Floor Muscle Training (PFMT)
This is the most consistently evidenced non-hormonal intervention. A systematic review and meta-analysis of 21 randomized controlled trials showed that pelvic floor muscle training improved arousal, orgasm, satisfaction, pain, and the Female Sexual Function Index overall score. No side effects of the interventions were reported.
Desire, arousal, lubrication, and orgasm domains were markedly improved among women with greater pelvic floor muscle strength, suggesting that stronger pelvic muscles are linked to fewer complaints of sexual dysfunction.
PFMT is not simply Kegel exercises performed mechanically. Effective training involves correct identification of the pelvic floor muscles (many women contract the wrong muscles), appropriate sequencing of contraction and relaxation, and in many cases, guidance from a pelvic floor physiotherapist. Women with hypertonic (overly tight) pelvic floors may actually need relaxation training rather than strengthening – which is why professional assessment is important.
Hormonal Interventions
Local vaginal estrogen restores genital tissue health – improving blood flow, tissue elasticity, and nerve sensitivity – without significant systemic absorption. This directly improves the physiological conditions for orgasm. Testosterone therapy, where indicated for HSDD, also improves orgasmic function as part of the broader restoration of sexual response.
Directed Self-Exploration and Mindfulness
Treatment options for FOD include cognitive-behavioral therapy, directed masturbation, pelvic floor muscle training, pharmacological interventions such as sildenafil, bupropion, or hormonal therapy, mechanical devices, and emerging regenerative therapies such as platelet-rich plasma and stem cell treatments.
Directed masturbation – a structured, therapist-guided program of self-exploration – has a strong evidence base for FOD and remains the most accessible first intervention for many women. Vibrators and other devices are not merely recreational; they are clinical tools that provide the level of direct stimulation many women now need, and their use should be destigmatized entirely.
Mindfulness-based approaches are also evidenced: reducing cognitive distraction during sexual activity (the “spectatoring” pattern, where a woman mentally observes rather than experiences) significantly improves orgasmic consistency.
The Honest Bottom Line
Orgasm changes after 40 are real, common, and rooted in specific physiological mechanisms. They do not mean you are broken, that your relationship has failed, or that this is simply “aging.” They mean your body has changed, and your approach to sexual pleasure may need to change with it – with more time, more direct stimulation, better pelvic floor function, and when appropriate, hormonal support.
Speak to a gynecologist or sexual therapist if these changes are bothering you. You deserve that conversation.
For more useful articles and expert guidance, explore the Womeno app – your personal digital companion through the hormonal transition. Download the app HERE.
Sources: Balasubramanian A et al. Sleep and Reproductive Health. PMC7101004. 2020; Jorge CH et al. Pelvic floor muscle training as treatment for female sexual dysfunction: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology. 2024;231(1):51–66. doi:10.1016/j.ajog.2024.01.006; Faucher S et al. Investigating the role of the pelvic floor muscles in sexual function and sexual response: a systematic review and meta-analysis. Journal of Sexual Medicine. 2024;21(3):217–239.; Pruccoli J et al. Female Orgasmic Disorder: How Far We Have [Not] Come? International Urogynecology Journal. 2025. doi:10.1007/s00192-025-06206-x; Nappi RE et al. GSM: Recommendations from the 5th ICSM 2024. Sexual Medicine Reviews. 2026;14(1). doi:10.1093/smr/qeaf055; Chubak B. Dyspareunia: From Concept to Care. AUA News. April 2024. auanews.net; Iglesias-Rios L et al. Evaluation and Treatment of Female Sexual Pain: A Clinical Review. PMC5969816. 2018.; Danan ER et al. Dyspareunia in Women. American Family Physician. 2021;103(10):597–604.; Mertens HJ et al. The Relationship Between Pelvic Floor Function and Sexual Function in Perimenopausal Women. PMC8766258. 2022.; Vidal A et al. Female Sexual Function and Pelvic Floor Muscle Training: A Narrative Review. PMC12247012. 2025.; Allen RE et al. Effects of age, menopause, and comorbidities on neurological function of the female genitalia. International Journal of Impotence Research. 2004. doi:10.1038/sj.ijir.3901230; Mües HM et al. Too stressed for sex? Associations between stress and sex in daily life. Psychoneuroendocrinology. 2025. doi:10.1016/j.psyneuen.2024.106045; Sbarra DA, Coan JA. Bidirectional associations between daily subjective stress and sexual desire, arousal, and activity. Annals of Behavioral Medicine. 2025. doi:10.1093/abm/kaaf007; Hamilton LD et al. Cortisol, Sexual Arousal, and Affect in Response to Sexual Stimuli. Journal of Sexual Medicine. 2008.; Rodríguez-Nieto G et al. The modulatory role of cortisol in the regulation of sexual arousal. Frontiers in Behavioral Neuroscience. 2020;14:552567.